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In Caenorhabditis elegans, two well-characterized TGF signaling cascades have been identified: the Small/Male tail
abnormal (Sma/Mab) and Dauer formation (Daf) pathways. The Sma/Mab pathway regulates body size morphogenesis and
male tail development. The ligand of the pathway, dbl-1, transmits its signal through two receptor serine threonine kinases,
daf-4 and sma-6, which in turn regulate the activity of the Smads, sma-2, sma-3, and sma-4. In general, Smads have been
shown to both positively and negatively regulate the transcriptional activity of downstream target genes in various
organisms. In C. elegans, however, target genes have remained elusive. We have cloned and characterized lon-1, a gene with
homology to the cysteine-rich secretory protein (CRISP) family of proteins. lon-1 regulates body size morphogenesis, but
does not affect male tail development. lon-1 is expressed in hypodermal tissues, which is the focus of body size
determination, similar to sma-2, sma-4, and sma-6. Using genetic methods, we show that lon-1 lies downstream of the
Sma/Mab signaling cascade and demonstrate that lon-1 mRNA levels are up-regulated in sma-6-null mutant animals. This
provides evidence that lon-1 is negatively regulated by Sma/Mab pathway signaling. Taken together, these data identify
lon-1 as a novel downstream target gene of the dbl-1 TGF-like signaling pathway. © 2002 Elsevier Science (USA)
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Transforming growth factor  (TGF) regulates many
cellular processes, including proliferation, differentiation,
development, and apoptosis. The TGF superfamily in-
cludes the TGFs, activins, and bone morphogenetic pro-
teins (BMPs). These ligands transmit their signal upon
binding to a type II receptor serine threonine kinase (RSK),
which in turn phosphorylates and activates a type I RSK.
The active type I RSK transmits the signal to downstream
molecules called Smads. The receptor-regulated Smads (R-
Smads) are phosphorylated by the type I RSK, which allows
them to form a complex with the common Smads (co-
Smads) and translocate to the nucleus. Once in the nucleus,
the Smads bind DNA and act as transcriptional regulators
(Heldin et al., 1997; Massague´, 1998; Patterson and Padgett,
2000; Whitman, 1998). An intense area of investigation is to
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418identify downstream target genes that mediate the diverse
functions of TGF.
In Caenorhabditis elegans, there are two well-studied
TGF-like signaling pathways, the Sma/Mab (Small/Male
tail abnormal) pathway and the Daf (dauer formation)
pathway (reviewed in Patterson and Padgett, 2000). The
Sma/Mab pathway regulates body size formation and male
tail development (Morita et al., 1999; Savage et al., 1996;
Suzuki et al., 1999). The dauer pathway regulates the
formation of an alternative larval stage when there is an
excessive population of worms and/or food is scarce (Riddle
and Albert, 1997). Entry into the dauer stage allows for
survival until resources are plentiful again. Both of these
pathways utilize a common type II RSK, daf-4 (Krishna et
al., 1999). daf-4 (lf) animals possess the phenotypes seen in
both Daf and Sma/Mab pathway mutants (Estevez et al.,
1993). These animals are dauer constitutive (develop into
dauer larvae when food is plentiful), are small in body size,
and males possess malformed tail rays and spicules.
Mutations in any of the known Sma/Mab pathway com-
ponents result in animals that are about 30% smaller in
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body size than wild-type animals but, unlike daf-4, have no
dauer phenotypes on their own (Estevez et al., 1993;
Krishna et al., 1999; Morita et al., 1999; Savage et al., 1996;
Suzuki et al., 1999). In the tail of male mutant animals, ray
fusions are seen between rays 4 and 5, 6 and 7, as well as 8
and 9 (Krishna et al., 1999; Savage et al., 1996; Savage-Dunn
et al., 2000). In addition, the copulatory spicules are
crumpled. These male tail defects prevent the male from
mating. The Sma/Mab ligand, dbl-1, and the RSKs, daf-4
and sma-6, transmit the TGF signal to the R-Smads.
However, in C. elegans, three Smads, sma-2, sma-3, and
sma-4, are required for proper TGF signaling as opposed to
the two interacting Smads seen in Drosophila and mamma-
lian systems. Once activated, the Smads translocate to the
nucleus and alter target gene transcription. In C. elegans,
very little is known about the downstream Sma/Mab path-
way targets.
In efforts to elucidate the downstream cellular outputs of
Sma/Mab pathway signaling, we examined long body sized
animals (Lon). Since overexpression of some Sma/Mab
pathway components leads to Lon body size, we reasoned
that lon-1, which also affects body size, might be involved
in Sma/Mab pathway signaling (Morita et al., 1999; Suzuki
et al., 1999). We find through epistatic analyses that lon-1
functions downstream of the Sma/Mab pathway compo-
nents in regards to regulating body size morphogenesis but
not male tail development. We have cloned lon-1 and find
that it encodes a protein with homology to several secreted
molecules of the cysteine-rich secretory protein (CRISP)
family (Kratzschmar et al., 1996). Although several diverse
molecules comprise the CRISP family, such as sperm-
coating glycoproteins, venom allergen 5, and PR-1 plant
pathogenesis proteins, little is understood about how they
function. We find that lon-1 is expressed in the hypodermis
and intestine, similar to the expression patterns seen for
known Sma/Mab pathway components. In addition, we
provide evidence that lon-1 function is required in the
hypodermis, and not the intestine, to regulate proper body
size formation. Examination of lon-1 mRNA levels shows
that mutations in Sma/Mab pathway signaling negatively
regulate lon-1 expression. Therefore, we conclude that
lon-1 is a Sma/Mab pathway target gene.
MATERIALS AND METHODS
C. elegans Strains
All strains were grown at 20°C and maintained by using standard
laboratory procedures (Brenner, 1974). The Bristol strain, N2, was
used as wild-type. sma-6(wk7) and lon-1(wk50) were used in
epistatic analyses. The triple mutant lon-1(e185) unc-119(e2498);
him-5(e1490) was used for cosmid rescue. lon-1(e185), lon-
1(n1130), lon-1(ct411), lon-1(wk49), lon-1(wk50), sma-6(wk7), and
N2 were used in developmental time course experiments. Genomic
DNA from lon-1(wk50), lon-1(e185), and lon-1(n1130) was se-
quenced to identify molecular lesions. RNA from a dbl-1 overex-
pressing strain, ctIs40 [pTG96 (sur-5::gfp), ZC421(dbl-1)], (Suzuki
et al., 1999) was used in Northern blot analyses described below.
Isolation of lon-1 Alleles
The canonical allele lon-1(e185) was isolated by Brenner (1974).
We isolated additional lon-1 mutants from an ethyl methanesulfo-
nate (EMS)-induced mutant F2 screen (unpublished data). lon-
1(wk49), lon-1(wk50), and lon-1(wk51) were identified based on
the long body size phenotype of mutagenized N2 animals and their
failure to complement lon-1(e185).
Cloning of lon-1
lon-1 was mapped to linkage group III between dpy-17 and sma-2
by Brenner (1974). Six cosmids corresponding to the lon-1 interval
were tested for transformation rescue by coinjecting with marker
plasmid containing wild-type unc-119 into lon-1(e185) unc-
119(e2498); him-5(e1490) triple mutant animals. Cosmid F48E8
conferred rescue. A genomic lambda library was screened in order
to isolate phage clones spanning the entire rescuing cosmid.
Subsequently, two of these phage clones conferred rescue, identi-
fying F48E8.1 as the lon-1 open reading frame.
We isolated a cDNA, B1.11, from a library (R. Barstead, personal
communication). We also obtained the cDNA yk298h6 from the C.
elegans cDNA Project (Y. Kohara, National Institute of Genetics).
Each cDNA was sequenced and compared with the genomic
sequence from cosmid F48E8. Both cDNAs contain six exons.
However, the first five exons are identical, while the sixth exon
differs (Figs. 1B and 1C).
To sequence mutant alleles, genomic DNA was isolated from
homozygous lon-1(wk50), lon-1(e185), and lon-1(n1130) animals.
To eliminate PCR errors, two independent samples for each primer
set and each worm strain were generated. The lon-1 region was
amplified by PCR using primer sets that spanned the genomic
region of lon-1 (CGGCGACTAGTCGGCTATATTGCAGATAC,
CGGCGCTCGAGGCAAAGCCAAAGGAGACA; CGGCGACT-
AGTTTTGAGTTTCTTGCTAAC, CGGCGCTCGAGTTAAAA-
CATAAACGGATC). All fragments were digested with SpeI and
XhoI, cloned into pBluescript SK, and sequenced.
Body Size Measurements
Images were taken of animals at L4 stage and 48 h later at a
magnification of 3.5 using a Nikon SMZ-U dissecting micro-
scope. The computer program used to capture the images was
Strata Video Shop (Strata Inc.) with screen dimensions 680  460
pixels. Once images were recorded, perimeter analysis on at least
19 animals was performed by using Image Pro Plus software
(Mediacybernetics).
Developmental Time Course Analysis
In order to obtain a synchronous population, gravid animals were
treated with a hypochlorite/NaOH solution to remove all animals
while leaving the eggs unaffected. Eggs were then placed into 10 ml
of M9 for 24 h and allowed to hatch at room temperature. L1
animals were plated onto OP50 seeded agar plates (time zero) and
allowed to develop at 20°C. Pictures were taken of animals at 24-h
intervals beginning at time zero. Time points were recorded
through 96 h.
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FIG. 1. lon-1 encodes two different transcripts. (A) Genetic map of the region surrounding lon-1. Cosmids spanning the lon-1 region were
injected into lon-1(e185) unc-119(e2498); him-5(1490) animals, and two phage clones containing the lon-1 ORF rescuing fragment were
isolated (3N20, 2N18). (B) Intron/exon structure of the two lon-1 cDNA molecules. In each cDNA, the first five exons are identical, while
the last exon differs. (C) The two predicted amino acid sequences of LON-1 resulting in proteins with different C-terminal ends. In
lon-1(e185) and lon-1(n1130), a cysteine is replaced by a tyrosine, while the asterisk denotes a premature stop codon in lon-1(wk50)
resulting in a truncated protein of 193 amino acids.
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lon-1p::gfp Fusion and Tissue-Specific
Expression Constructs
Sequence corresponding to 3 kb upstream of the predicted lon-1
start site was cloned into the GFP insertion vector pPD95.69 (A.
Fire, Carnegie Institute of Washington). To analyze expression
patterns, this construct was coinjected with pRF4 [rol-6(su-1006)]
(Mello et al., 1991) into N2 animals. The extrachromosomal array
was integrated into the genome by exposing animals to gamma
irradiation and observing the F2 population for a 100% roller
phenotype (Mello and Fire, 1995). GFP fluorescence was visualized
by using a Zeiss compound microscope.
Tissue-specific expression constructs were generated by cloning
PCR products from the promoter regions of rol-6, elt-2, and elt-3
into pBluescript SK (Gilleard et al., 1999; Hawkins and McGhee,
1995; Mello et al., 1991). A 1-kb PCR fragment containing a portion
of the elt-2 promoter was generated by using the primers CCATA-
AATTCTTGAAAGCTTTTGAT and CCGGTCTAGAGTGTAT-
AATCTATTTTCTAGTTTCTA. A 2-kb PCR fragment containing
a portion of the elt-3 promoter was generated by using the primers
CCGGAAGCTTGTGACACGTTGTTTCACGGTCAT and CCG-
GTCTAGAGAAGTTTGAAATACCAGGTAGCCGA. For rol-6,
an 800-bp fragment containing a portion of its promoter was
generated by using the primers CCGGAAGCTTCTTCGTATTA-
GATCTCAGCAGC and CCGGTCTAGACAGTTAGATCTAAA-
GATATATCCAG. These products were inserted into pBluescript
SK at the HindIII and XbaI sites. A 4.8-kb PCR product spanning
the lon-1 genomic region was generated with the primer set
CCGGGCGGCCGCCAAAATGAATTATCTGTTGACTGCTCTG
and CGCGCCGCGGTTTTCATCGATATATTTGAGTTCTTTT-
GATT, digested with NotI and SacII, and inserted into the con-
structs above containing the tissue-specific promoters. Each
construct was then microinjected into lon-1(wk50) animals and
analyzed for transformation rescue of body size. As controls, each
promoter fragment described above was inserted into the promot-
erless gfp insertion vector pPD95.75 (A. Fire, Carnegie Institute of
Washington) at the HindIII and XbaI sites, injected into lon-
1(wk50) animals, and expression patterns were analyzed.
Northern Blots
To analyze transcriptional regulation of the lon-1 locus,
total RNA was collected from N2, sma-6(wk7), ctIs40[pTG96
(sur-5::gfp), ZC421(dbl-1)], and lon-1(wk50) L4 animals. A synchro-
nous population was generated as described above. L4 animals were
washed off plates with M9. Pelleted animals were resuspended in
100 l Trizol (Gibco/BRL) and freeze-thawed three times. After the
third thaw, samples were homogenized for approximately 5 min.
Sample volumes were adjusted to 500 l with Trizol, incubated for
5 min at room temperature, and then 100 l of chloroform was
added. The solution was shaken vigorously and centrifuged at
12,000g for 10 min at 4°C. The aqueous phase was precipitated
with 500 l of isopropanol and the pellet was washed with 75%
ethanol.
Total RNA (20–30 g) was loaded per lane onto a 1.2% agarose/
6.6% formaldehyde gel. After gel electrophoresis, the samples were
transferred to nitrocellulose (Osmonics Inc.) and baked for 2 h at
80°C. The lon-1 probe was generated from an EcoRI fragment
digested from the lon-1 cDNA, B1.11. Probes were labeled by using
the Prime-It II kit (Stratagene). The blot was prehybridized for at
least 30 min in 1 mM EDTA, 0.5 M NaPO4, pH 7.2, 7% SDS, and
1% BSA fraction V (Sigma) at 65°C. Probes were added to the
prehybridization solution and incubated overnight at 65°C. Each
blot was washed three times for 15 min at 65°C in a wash
containing 1 mM Na2EDTA, 40 mM NaPO4, pH 7.2, and 1% SDS.
After the last wash, blots were placed onto a phosphorimager
screen and analyzed by using a Molecular Dynamics PhosphorIm-
ager (Amersham Biosciences).
RESULTS
lon-1 Affects Body Size and Is Epistatic
to Sma/Mab Pathway Components
Mutations in any of the known Sma/Mab pathway com-
ponents (dbl-1, daf-4, sma-6, sma-2, sma-3, and sma-4)
result in animals with body size defects and male tail
abnormalities (Estevez et al., 1993; Krishna et al., 1999;
Morita et al., 1999; Savage et al., 1996; Suzuki et al., 1999).
Body sizes are approximately 70% of the wild-type body
length. Examination of Sma/Mab mutant male tails reveals
that several sensory rays are fused to one another. Ray
fusions occur between rays 4 and 5, rays 6 and 7, and rays 8
and 9 with a higher percentage of fusions observed between
rays 6 and 7 (Savage et al., 1996). In addition, the copulatory
spicules are crumpled. Since TGF-like signaling in C.
elegans affects body size morphogenesis, we decided to
investigate body size regulation in lon-1 mutants. Muta-
tions in lon-1 result in worms that are approximately 25%
longer than wild-type animals. Double mutants consisting
of lon-1 and each of the following, sma-6(wk7), dbl-
1(wk70), sma-2(e502), sma-3(wk30), and sma-4(e729), re-
sult in worms which are longer in body size than wild-type
animals, therefore placing lon-1 downstream of the Sma/
Mab pathway components (Table 1; and data not shown).
Although lon-1(lf) suppresses the small body size pheno-
type seen in the Sma/Mab pathway components, it does not
suppress the ray fusion defects (data not shown).
lon-1 Encodes a Protein with Homology
to the CRISP Family of Proteins
In order to understand how lon-1 functions, we under-
took the molecular cloning of lon-1. lon-1 was first identi-
fied and mapped to an interval on chromosome III by
Brenner (1974). We have rescued the lon-1 mutant pheno-
type by cosmid injection (Fig. 1A). Cosmid F48E8 not only
rescued the lon-1 phenotype, but also occasionally con-
TABLE 1
Epistatic Analysis between lon-1 and Sma/Mab
Pathway Components
Mutant Perimeter (mm) n
N2 2.44  0.16 40
sma-6(wk7) 2.01  0.14 42
lon-1(wk50) 2.88  0.15 42
sma-6(wk7);lon-1(wk50) 2.63  0.14 42
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ferred a small body size phenotype (data not shown). This
suggests that proper dosage of lon-1 is required for correct
body size formation. To identify the lon-1 open reading
frame (ORF), we isolated genomic clones and found that
two of these, 2N18 and 3N20, also rescued (Fig. 1A). A
construct containing a single ORF common to each clone,
corresponding to F48E8.1, also conferred rescue, indicating
that it is the lon-1 transcript (Table 2).
To prove that this ORF correlates with the lon-1 tran-
script, we set out to identify molecular lesions in lon-
1(wk50), lon-1(e185), and lon-1(n1130). Mutant lon-1 loci
were amplified and sequenced. lon-1(e185) and lon-
1(n1130) have an identical mutation, a nucleotide base
change from G to A resulting in an amino acid change from
cysteine to tyrosine at amino acid position 185. lon-
1(wk50) animals have a mutation that results in a prema-
ture stop codon at amino acid position 194 and, therefore, a
truncated protein (Fig. 1C). Taken together, these data
confirm F48E8.1 as the lon-1 transcript. It is likely that
these nucleotide changes in the lon-1 transcript do not
result in null phenotypes. It has previously been reported
that overexpression of dbl-1 in a lon-1(lf) background re-
sults in animals which are longer than mutants alone
(Morita et al., 1999). The phenotypes in the lon-1 alleles
used in this study are not as severe as lon-1(e185), suggest-
ing that they are hypomorphic alleles.
After identifying the lon-1 ORF, we obtained two lon-1
cDNAs. We isolated B1.11 by screening a cDNA library (R.
Barstead, personal communication) for the lon-1 transcript.
An additional cDNA, yk298h6, was obtained from the C.
elegans cDNA project (Y. Kohara, National Institute of
Genetics). Both cDNA transcripts contain six exons. How-
ever, the sixth exon differs between the two. To rule out the
possibility that one of these cDNAs is an aberrant form
made during library construction, PCR amplification from
the ACT-RB2 (R. Barstead, personal communication)
cDNA library was performed. The presence of both lon-1
transcripts was detected, suggesting that there are two
forms of lon-1. Each is spliced differently between the fifth
and sixth exons resulting in proteins with different
C-terminal ends (Fig. 1B). The two different lon-1 tran-
scripts, yk298h6 and B1.11, encode predicted proteins of
313 and 337 amino acids, respectively. Each protein con-
tains a predicted secretion signal at its N terminus and a
region of approximately 155 amino acids that shows homol-
ogy to extracellular proteins of the CRISP superfamily. This
family includes the sperm-coating glycoproteins, vespid
wasp venom allergen 5 (Ag5), plant pathogenesis proteins of
the PR-1 family, and human glioma pathogenesis-related
protein (GliPR) (Fig. 2). Members of this family are very
diverse and little is known about how they function. This
family is defined by a region of several conserved cysteine
residues within the carboxyl-terminal domain, as well as a
hydrophobic signal sequence at the amino terminus.
LON-1 Is Expressed in Hypodermal
and Intestinal Cells
To determine where lon-1 functions, we examined its
expression patterns in vivo. Approximately 3 kb of the lon-1
promoter upstream of the start site was fused to gfp
(lon-1p::gfp). This construct was injected into wild-type
animals and its expression pattern was examined. We see
similar patterns of expression from early larval stages
through the adult stage (Figs. 3A, 3C, and 3E; data not
shown). In L1 hermaphrodites, expression can be seen in the
intestine, with the posterior gut showing more expression
than the anterior gut. In the posterior-most part of the
hermaphrodite, the hypodermal tail region also expresses
this reporter. Occasionally, in the head, hypodermal regions
show expression along with a pair of unidentified neurons.
L4 and adult animals show a similar expression pattern to
that seen in L1 hermaphrodites. In addition, L4 and adult
animals show expression in hypodermal regions through
the entire body length of the animal. Four stripes of alter-
nating thickness can be seen, originating in the hypodermal
regions of the head and spanning the length of the animal to
the posterior most hypodermal regions of the tail.
Expression constructs with Smad promoters (sma-2p::gfp,
sma-4p::gfp, and sma-3p::lacZ) as well as the type I RSK
promoter (sma-6p:: gfp) also show similar temporal and
spatial expression patterns to those observed for lon-1p::gfp
(Savage-Dunn et al., 2000; Yoshida et al., 2001; data not
shown). This includes the hypodermal stripes that extend
the entire body length of the animal. This result suggests
that lon-1 may function together with Smads to regulate
body size development.
Hypodermal Expression Is Sufficient
for Rescue of the lon-1 Phenotype
Since lon-1p::gfp is expressed in the hypodermal and
intestinal regions of the animal, we asked whether lon-1
functions in these tissue types as well. Promoters that drive
expression in specific tissues were fused to lon-1 genomic
DNA. Tissue-specific promoters used in this study included
rol-6 (hypodermal expression), elt-2 (intestinal expression),
and elt-3 (hypodermal expression) (Gilleard et al., 1999;
Hawkins and McGhee, 1995). As controls, each promoter
driving GFP expression alone was analyzed for expected
TABLE 2
Rescue of lon-1(wk50) by Promoter Fusion Constructs
Genotype
Perimeter of adult
(mm) n
N2 2.56  0.11 23
lon-1(wk50) 2.95  0.13 46
lon-1(wk50);rol-6p::lon-1 (hyp6, hyp7) 2.57  0.15 36
lon-1(wk50);elt-2p::lon-1 (intestine) 2.84  0.27 19
lon-1(wk50);elt-3p::lon-1 (hypodermis) 2.36  0.59 22
lon-1(wk50);lon-1p::lon-1 2.39  0.19 30
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tissue-specific expression (data not shown). Each construct
was injected into lon-1(wk50) animals and multiple trans-
genic strains were analyzed. A representative strain is
shown (Table 2). We find that lon-1 genomic DNA under
control of the hypodermal specific promoters, rol-6 or elt-3,
is able to rescue the long body size phenotype of lon-
1(wk50) animals to that of wild-type body size. Quite often
these constructs also conferred a small phenotype, which
would be expected if lon-1 were to function with the
Sma/Mab pathway components to regulate body size mor-
phogenesis. However, lon-1 genomic DNA under the con-
trol of elt-2, the intestinal-specific promoter, did not rescue
the long body size phenotype, suggesting that lon-1 func-
tion is dispensable in the intestine for regulating body size.
lon-1 Animals Differ in Body Length Compared
with Wild-Type at Later Developmental Stages
Previously, it has been demonstrated that Sma/Mab mu-
tant animals are the same length as wild-type animals at
hatching (Savage-Dunn et al., 2000); L1 larvae of sma-2,
sma-3, sma-6, and dbl-1 are indistinguishable in length
from N2 larvae. As the Sma/Mab pathway mutant animals
develop postembryonically, they are approximately 70%
the size of wild-type animals 96 h after hatching (Savage-
Dunn et al., 2000). We wondered whether lon-1 mutant
animals develop in a manner comparable to the Sma/Mab
pathway mutant animals. Are lon-1 animals longer in body
length than wild-type animals at hatching, or are the L1
larvae identical in body length to that of wild-type animals?
We find that the L1 larvae of lon-1(e185), lon-1(wk50),
lon-1(n1130), lon-1(ct411), and lon-1(wk49) are indistin-
guishable from wild-type and Sma/Mab mutant L1 larvae
(Fig. 4; and unpublished data). This suggests that the defects
seen in the altered body morphology of lon-1 mutant
animals, like those of Sma/Mab mutant animals, are a
result of postembryonic events. In contrast, sma-1, which is
not a Sma/Mab pathway component, produces L1 larvae
that are approximately half the size of wild-type animals
(McKeown et al., 1998). We also see that the lon-1 mutants
gradually get longer in body length compared with wild-
type animals as they pass through the remaining larval
stages and eventually become adults.
The Sma/Mab Pathway Regulates lon-1 Expression
In various organisms, TGF signaling regulates the tran-
scriptional activity of many genes. However, very few
FIG. 2. lon-1 encodes a protein with homology to members of the CRISP superfamily. (A) Schematic of LON-1. Hatched area is region of
LON-1 that shows homology to members of the CRISP superfamily. (B) Percent similarities and identities of the homologous region found
between LON-1 and several CRISP superfamily members: Ce LON-1, C. elegans LON-1; At PR1, Arabodopsis thaliana pathogenesis-
related protein 1; Hs GliPR, Homo sapiens glioma pathogenesis-related protein; Hs TPX-1, Homo sapiens testis-specific antigen; vw VA5,
vespid wasp venom allergen 5; wh VA5, white hornet venom allergen 5; Dm VA5–2, Drosophila melanogaster venom allergen 5–2; Dm
CG8483, D. melanogaster predicted CRISP family member. (C) Alignment of the hatched region of LON-1 shown in (A) and the
corresponding regions found within several CRISP family members. Asterisks indicate the conserved cysteines found in these proteins. The
circled asterisk identifies one of the conserved cysteines mutated in lon-1(e185) and lon-1(n1130).
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downstream target genes regulated by the C. elegans Sma/
Mab pathway have been characterized. Since lon-1 is epi-
static to known Sma/Mab pathway signaling components
(Table 1), we wondered whether Sma/Mab pathway signal-
ing might negatively regulate lon-1 mRNA expression lev-
els. Total RNA from N2, sma-6(wk7), ctIs40[pTG96
(sur-5::gfp), ZC421(dbl-1)], and lon-1(wk50) animals was
isolated from synchronous populations of L4 animals and
used for Northern blot analyses. The sma-6(wk7)-null allele
was used to provide RNA from an animal where Sma/Mab
pathway signaling is lost. In ctIs40[pTG96 (sur-5::gfp),
ZC421(dbl-1)] animals, dbl-1 is overexpressed, which leads
to an up-regulation of pathway signaling. We observe that
lon-1 mRNA levels are up-regulated in sma-6(wk7) and
down-regulated in ctIs40[pTG96 (sur-5::gfp), ZC421(dbl-1)];
quantitation shows a difference of approximately 45%. This
difference is reproducible and consistent with negative
regulation of the lon-1 message by the Sma/Mab pathway
(Fig. 5, lanes 3 and 2, respectively).
DISCUSSION
lon-1 Regulates Body Size
Although the Sma/Mab pathway regulates body size
formation, little is understood about the molecular mecha-
nism of this regulation. The Sma/Mab pathway compo-
nents are expressed in various tissues throughout develop-
ment. The ligand dbl-1 is expressed mostly in neurons
found in the ventral nerve cord and pharynx, while the type
I RSK, sma-6, is expressed in pharyngeal muscles, intestinal
cells, and hypodermal tissues (Krishna et al., 1999; Suzuki
et al., 1999). daf-4, the type II RSK, partially functions in
pharyngeal, muscular, and hypodermal tissues to regulate
body size (Inoue and Thomas, 2000). The Smads sma-2,
sma-3, and sma-4 are also expressed in hypodermal tissues,
further implicating the hypodermis as the site responsible
for regulation of body size (unpublished data; Savage-Dunn
et al., 2000). Our work presented here provides compelling
evidence that body size is regulated in the hypodermal
tissues of C. elegans. We see that lon-1, when expressed
specifically in hypodermal tissues under the control of the
rol-6 or elt-3 promoters, is able to rescue the Lon phenotype
of lon-1(wk50) animals to that of wild-type, while lon-1
expression under the control of the intestinal promoter
elt-2 has no effect on body size (Table 2). Although expres-
sion of lon-1() in the intestine has no effect on body size,
lon-1 is expressed in the intestine, suggesting that it may
play a yet to be identified role in the intestine.
The Sma/Mab Pathway Branches Downstream
of the Smads
Mutations in any of the Sma/Mab pathway components,
dbl-1 (ligand), sma-6 (RSK I), daf-4 (RSK II), sma-2 (Smad),
sma-3 (Smad), or sma-4 (Smad), result in animals that are
about 70% the size of wild-type animals (Estevez et al.,
1993; Krishna et al., 1999; Morita et al., 1999; Savage et al.,
1996; Suzuki et al., 1999). In addition, male mutant animals
have defects in their tail rays and spicules. Double mutants
made between any of the Sma/Mab pathway components
and lon-1 result in animals that are Lon, indicating that
lon-1 is epistatic to Sma/Mab pathway signaling. Although
lon-1 is able to suppress the small body size phenotype, it is
unable to rescue the male tail defects also found in the
Sma/Mab pathway mutants (unpublished data). This sug-
gests that the Sma/Mab pathway may branch downstream
of Smad (sma-2, -3, and -4) activity. Once the Smads
translocate into the nucleus, they would then be able to
regulate a variety of genes. A subset of these genes may only
FIG. 3. Expression patterns of lon-1p::gfp in wild-type animals.
Fluorescent images (A, C, E) are on the left, while Nomarski images
(B, D, F) of the same animals are on the right. Hypodermal regions
express lon-1p::gfp in a striped pattern down the entire length of the
animal in L1 (not shown), L4 (A), and adult (C) animals. Expression
is also observed in the anterior and posterior regions of the
intestine in L4 animals (data not shown) and adults (E).
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affect body size formation, while others might only regulate
male tail morphogenesis. Further evidence in support of
pathway branching is observed in a weak allele of sma-6,
where the small body size phenotype is observed without
defects in male tail rays, thus arguing that body size
morphogenesis and male tail formation are separable func-
tions (Krishna et al., 1999). Alternatively, lon-1 might not
suppress the tail defects seen in Sma/Mab pathway mutants
because the alleles used in this study may not be null
mutations. Previously, it has been shown that overexpres-
sion of dbl-1 in the lon-1(e185) background results in
animals which are longer than lon-1(e185) animals alone,
suggesting that lon-1(e185) is not null (Morita et al., 1999).
Although the lon-1(wk50) lesion is likely to result in a
truncated protein, the Lon phenotype seen in these ani-
mals is less severe than that seen in lon-1(e185) animals
and suggests that the truncated protein maintains partial
function.
Negative Regulation of the lon-1 Transcript
Affects Body Size Formation
Because defects in Sma/Mab pathway signaling and mu-
tations in lon-1 affect body size, we reasoned that lon-1
might somehow be involved in regulating body size in
conjunction with the Sma/Mab pathway components.
Double mutants made between the null allele of sma-6 and
lon-1 are Lon, therefore eliminating the possibility that
lon-1 acts as a negative regulator of the pathway. This
evidence led us to hypothesize that lon-1 is negatively
regulated by the Sma/Mab signaling pathway. In sma-
6(wk7)-null mutants, the Smads sma-2, sma-3, and sma-4
would not be activated, would not translocate to the
nucleus, and would not bind the lon-1 promoter. Therefore,
the lon-1 message would become up-regulated in the ab-
sence of the Smads. The absence of Smad binding might
allow for other molecules to bind to and positively regulate
the lon-1 promoter. Conversely, excess ligand may over-
FIG. 4. lon-1 animals are longer in length than wild-type animals at later developmental stages. lon-1(e185), sma-6(wk7), and N2 animals
were synchronized and measured at 24-h time points starting with L1 larvae at time zero. All animals are indistinguishable in length as L1
larvae. Over time, Lon animals gradually develop a longer body length than wild-type animals. The perimeter of at least 30 animals for each
strain was measured and averaged at each time point.
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stimulates the pathway, resulting in increased RSK activ-
ity. This increased activity would signal more Smads into
the nucleus, which in turn would bind the lon-1 promoter
and decrease the expression levels of the lon-1 message.
In fact, we observe that the lon-1 message is up-regu-
lated in sma-6(wk7) animals, and is down-regulated in
ctIs40[pTG96(sur-5::gfp), ZC421(dbl-1)] animals where
dbl-1 ligand is overexpressed. The difference seen in lon-1
mRNA levels between the animals lacking sma-6(wk7)
and those overexpressing dbl-1 is approximately 45%. It is
likely that the transcriptional control of the lon-1 message
is complex. It is quite possible that there are other regula-
tory molecules in addition to the Smads that modulate
lon-1 expression. Expression of lon-1 mRNA is still observed
in animals overexpressing dbl-1 (ctIs40[pTG96(sur-5::gfp),
ZC421(dbl-1)]), indicating that the regulation of lon-1 mRNA
levels is not a simple ON/OFF mechanism. It is probable
that wild-type body size is maintained by proper dosage of
LON-1, and either too much or too little lon-1 mRNA
results in small or long body sized animals, respectively.
Smads have been shown to bind DNA in a sequence-
specific manner. Human Smad3 and Smad4, Drosophila
Mad, and C. elegans DAF-3 bind to specific consensus sites
in various TGF responsive promoters (Kim et al., 1997;
Thatcher et al., 1999; Zawel et al., 1998). Examination of
the lon-1 promoter sequence reveals three well-conserved
Smad binding sites upstream of the lon-1 ATG. Each of
these binding sites shows high homology to the sites bound
by human Smad3 and 4, Drosophila Mad, and C. elegans
DAF-3. The presence of putative Smad binding sites in the
lon-1 promoter provides a possible molecular explanation
for our findings that lon-1 is transcriptionally regulated by
the Sma/Mab pathway.
lon-1 Encodes Two Different Transcripts
We have identified two different lon-1 cDNA clones from
independent cDNA libraries. Both cDNAs were also ampli-
fied from a third independent cDNA library, supporting the
existence of two lon-1 mRNAs. Each cDNA contains six
exons; one through five are identical, while the sixth differs.
The different C-terminal domains found in each protein are
likely to determine their functional roles. Whether both of
these cDNA forms are required for proper body size forma-
tion remains to be determined. The C-terminal domain of
LON-1 may contain some sort of regulatory domain, found
in one protein and not the other, needed for proper func-
tioning relative to body size morphogenesis. It is important
to remember that lon-1 expression is observed in the
intestinal tissues but is not required for body size forma-
tion. Therefore, one or both transcripts may also play a role
in the intestine.
LON-1 Is a Member of the CRISP Superfamily
lon-1 encodes a protein with sequence similarity to a
diverse family of proteins referred to as the CRISP super-
family; these proteins are secreted, and possess several
conserved cysteine residues (Kratzschmar et al., 1996). This
family consists of numerous proteins, including the human
GliPR protein, antigen 5, testes-specific proteins, and sev-
eral plant pathogenesis-related (PR) proteins. The human
GliPR protein is highly expressed in the tumor glioblas-
toma multiforme, but not in normal fetal or adult brain
tissues (Murphy et al., 1995). These tumors derive from
immunological tissues and comprise more than half of the
human primary tumors identified in the brain (Morris and
Schoene, 1984). GliPR protein possesses a high degree of
identity (37–42%) with the plant PR-1 proteins, which have
been shown to be important in mechanisms involved in
plant defense systems (Bol et al., 1990; Murphy et al., 1995).
In addition, antigen 5 from vespid wasp venom and testes-
specific proteins are structurally related to the PR-1 pro-
teins, but to a lesser extent than the GliPR protein (Charest
et al., 1988; Kasahara et al., 1989; King et al., 1990; Lu et al.,
1993; Murphy et al., 1995). TPX-1 (also identified as
CRISP-2) is a testes-specific protein involved in the differ-
entiation of spermatogenic cells (Maeda et al., 1998). While
it is clear that these proteins share functional modules that
are utilized to regulate a wide variety of biological pro-
cesses, a mechanistic explanation for the specific molecular
role of these domains remains elusive. How C. elegans
LON-1 functions in relation to these proteins remains to be
determined. It is possible that LON-1 is secreted from the
hypodermal cells and functions as a ligand for another
signaling pathway, or as a matrix scaffolding protein. A
FIG. 5. lon-1 mRNA levels are negatively regulated by Sma/Mab
pathway signaling. Northern blot showing lon-1 mRNA transcripts
found in total RNA isolated from N2 (lane 1), dbl-1 (ctIs40; see
Materials and Methods) (lane 2), sma-6(wk7) (lane 3), and lon-
1(wk50) (lane 4) L4 animals. lon-1 transcripts are up-regulated in
sma-6(wk7) animals where Sma/Mab pathway signaling is greatly
reduced (lane 3). However, in dbl-1 animals, which overexpress
dbl-1 (ligand) and increase pathway signaling, lon-1 mRNA is
reduced (lane 2). lon-1 mRNA from lon-1(wk50) animals is mini-
mal (lane 4). Elongation factor-2 (eft-2) was used as a control to
measure the amount of total RNA loaded into each lane. mRNA
amounts were quantitated by using a phosphorimager.
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Drosophila homolog has also been identified; however,
mutants have yet to be described. Once characterized, any
Drosophila mutations may provide additional insights into
LON-1 function. We have performed genetic screens to
suppress the lon-1 phenotype in C. elegans and have iden-
tified small mutant animals. Cloning and characterization
of these genes may help in determining the role lon-1 plays
in C. elegans body size morphogenesis.
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